Praxis Precision Medicines Inc (PRAX) last year’s performance of 476.72% is a clear signal for an entertaining trading season.

On Monday, Praxis Precision Medicines Inc (NASDAQ: PRAX) opened higher 8.93% from the last session, before settling in for the closing price of $77.88. Price fluctuations for PRAX have ranged from $13.01 to $78.08 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted 46.64% at the time writing. With a float of $17.22 million, this company’s outstanding shares have now reached $18.64 million.

The firm has a total of 82 workers. Let’s measure their productivity. In terms of profitability, gross margin is 79.44%, operating margin of -10219.0%, and the pretax margin is -9409.22%.

Praxis Precision Medicines Inc (PRAX) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Praxis Precision Medicines Inc is 7.63%, while institutional ownership is 95.41%.

Praxis Precision Medicines Inc (PRAX) Recent Fiscal highlights

If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -2.97 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -3.18) by 0.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.38 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 46.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -14.60% during the next five years compared to -10.28% drop over the previous five years of trading.

Praxis Precision Medicines Inc (NASDAQ: PRAX) Trading Performance Indicators

Check out the current performance indicators for Praxis Precision Medicines Inc (PRAX). In the past quarter, the stock posted a quick ratio of 10.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1021.27.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.30, a number that is poised to hit -2.79 in the next quarter and is forecasted to reach -11.14 in one year’s time.

Technical Analysis of Praxis Precision Medicines Inc (PRAX)

Analysing the last 5-days average volume posted by the [Praxis Precision Medicines Inc, PRAX], we can find that recorded value of 0.59 million was better than the volume posted last year of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 92.56%. Additionally, its Average True Range was 5.01.

During the past 100 days, Praxis Precision Medicines Inc’s (PRAX) raw stochastic average was set at 96.03%, which indicates a significant increase from 92.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.46% in the past 14 days, which was lower than the 59.05% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $65.32, while its 200-day Moving Average is $53.14. Now, the first resistance to watch is $88.47. This is followed by the second major resistance level at $92.11. The third major resistance level sits at $97.41. If the price goes on to break the first support level at $79.53, it is likely to go to the next support level at $74.23. Now, if the price goes above the second support level, the third support stands at $70.59.

Praxis Precision Medicines Inc (NASDAQ: PRAX) Key Stats

There are currently 18,638K shares outstanding in the company with a market cap of 1.63 billion. Presently, the company’s annual sales total 2,450 K according to its annual income of -123,280 K. Last quarter, the company’s sales amounted to 360 K and its income totaled -32,680 K.